FDA Releases Guidance on Reprint Practices for Medical Journal Articles and Unapproved Drug Uses

Summary

The FDA has made available a guidance document outlining its expectations for the distribution of medical journal articles and scientific publications discussing unapproved new uses of approved drugs and medical devices to healthcare professionals and entities.